Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number 0-26301 United Therapeutics Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 52-19847 ...

United Therapeutics Corporation (NASDAQ:UTHR) Q4 2019 Earnings Conference Call February 26, 2020 9:00 AM ET Company Participants Dewey Steadman - Head of IR James Edgemond - CFO and Treasurer Martine Rothblatt - Chairman and CEO Michael Benkowitz - President and COO Leigh Peterson - VP, Product Development Conference Call Participants Chris Shibutani - Cowen Liana Moussatos - Wedbush Securities Jessica Fye - JPMorgan Hartaj Singh - Oppenheimer Thomas Deal - Credit Suisse Eun Yang - Jefferies Geoff Meacham - ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number 0-26301 United Therapeutics Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Oth ...

UNITED THERAPEUTICS CORPORATION J.P. Morgan Healthcare Conference January 13, 2020 SAFE HARBOR STATEMENT | --- | --- | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

United Therapeutics Corporation (NASDAQ:UTHR) Q3 2019 Earnings Conference Call October 30, 2019 9:00 AM ET Company Participants James C. Edgemond - CFO & Treasurer Dr. Martine A. Rothblatt - Chairman and CEO Michael I. Benkowitz - President and COO Conference Call Participants Jessica Fye - JP Morgan Martin Auster - Credit Suisse Liana Moussatos - Wedbush Securities Hartaj Singh - Oppenheimer & Company Operator Good morning and welcome to the United Therapeutics Corporation Third Quarter 2019 Earnings Call. ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2019 Delaware 52-1984749 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 1040 Spring Street, Silver Spring, MD 20910 (Address of Principal Executive Offices) (Zip Code) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 1 ...

United Therapeutics Corporation (NASDAQ:UTHR) Q2 2019 Results Conference Call July 31, 2019 9:00 AM ET Company Participants James Edgemond - CFO Dr. Martine Rothblatt - Chairman and CEO Michael Benkowitz - President and COO Conference Call Participants Hartaj Singh - Oppenheimer & Company Jessica Fye - JP Morgan Liana Moussatos - Wedbush Securities Chris Shibutani - Cowen Martin Auster - Credit Suisse Operator Good morning and welcome to the United Therapeutics Corporation Second Quarter 2019 Earnings Call. ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number 0-26301 United Therapeutics Corporation (Exact Name of Registrant as Specified in Its Charter) (301) 608-9292 (Re ...

UNITED THERAPEUTICS CORPORATION Jeffries 2019 Healthcare Conference June 4, 2019 UTHR / Jefferies HC 2019 SAFE HARBOR STATEMENT Remarks today concerning United Therapeutics may include forwardlooking statements which represent United Therapeutics' expectations or beliefs regarding future events. We caution that such statements involve risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements. Consequently, all such forward-looking statements are ...

United Therapeutics Corporation (NASDAQ:UTHR) Q1 2019 Results Earnings Conference Call May 1, 2019 9:00 AM ET Company Participants James Edgemond - Chief Financial Officer Martine Rothblatt - Chairman, Chief Executive Officer Michael Benkowitz - President, Chief Operating Officer Conference Call Participants Chris Shibutani - Cowen Liana Moussatos - Wedbush Securities Jessica Fye - JPMorgan Terence Flynn - Goldman Sachs Operator Good morning and welcome to the United Therapeutics Corporation first quarter 2 ...